TUSC2 downregulates PD-L1 expression in non-small cell lung cancer (NSCLC)

Expression of the TUSC2 tumor-suppressor gene in TUSC2-deficient NSCLC cells decreased PD-L1 expression and inhibited mTOR activity. Overexpressing TUSC2 or treatment with rapamycin resulted in similar inhibition of PD-L1 expression. Both TUSC2 and rapamycin decreased p70 and SK6 phosphorylation, su...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Cao, Xiaobo, Zhao, Yang, Wang, Jing, Dai, Bingbing, Gentile, Emanuela, Lin, Jing, Pu, Xingxiang, Ji, Lin, Wu, Shuhong, Meraz, Ismail, Majidi, Mourad, Roth, Jack A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2017
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5746095/
https://ncbi.nlm.nih.gov/pubmed/29296193
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22581
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak